تجاوز إلى المحتوى الرئيسي
drug protocol number
RC20/220/R
drug sponsor
KAIMRC
drug study
Favipiravir
drug trial site
King Abdulaziz Medical City NG (Riyadh)
drug status
Ongoing
drug phase